UK Soft Gelatin Capsules Market Outlook to 2030
By Shell Type, By Fill/Application, By Release Profile, By End Use, By Distribution Channel, and By Region
Report Overview
Report Code
TDR0364
Coverage
Europe
Published
October 2025
Pages
80
Flexible Purchase Options
Select and purchase only the chapters you need for your strategic decisions
On This Page
Report Overview
Executive summary will be available soon.
Report Coverage
Verified Market Sizing
Multi-layer forecasting with historical data and 5–10 year outlook
Deep-Dive Segmentation
Cross-sectional analysis by product type, end user, application and region
Competitive Benchmarking & Positioning
Market share, operating model, pricing and competition matrices
Actionable Insights & Risk Assessment
High-growth white spaces, underserved segments, technology disruptions and demand inflection points
Review Methodology & Data Structure
Preview report structure, data sources and research framework
Executive Summary
Explore Flexible Purchase Options or Have Limited Budget?
Pay only for relevant chapters • Customizable report sections
Table of Contents
Choose individual sections to purchase. Mix and match as you like.
4.1. Delivery Model Analysis for Softgel Manufacturing (In-House, Outsourced CDMOs, Hybrid Models-Margins, Preferences, Strengths, Weaknesses)
4.2. Revenue Streams for UK Soft Gelatin Capsules Market (Rx, OTC, Nutraceuticals, Private-Label, Exports, Licensing)
4.3. Business Model Canvas for UK Soft Gelatin Capsules Market
5.1. Freelance/Small-Scale Encapsulators vs. Full-Scale CDMOs
5.2. Investment Model in UK Soft Gelatin Capsules Market (CAPEX for rotary-die lines, drying tunnels, solvent recovery systems)
5.3. Comparative Analysis of Production & Approval Funnel (MHRA vs. FSA pathways; Pharma vs. Food Supplements)
5.4. Softgel Budget Allocation by Company Size (Global Pharma, Mid-Sized Nutraceuticals, SMEs/Private Label)
8.1. Revenues, Historical
9.1. By Market Structure (In-House and Outsourced Softgel Manufacturing)
9.2. By Capsule Type (Bovine Gelatin, Fish Gelatin, Vegetarian/Carrageenan, Tapioca/Starch Blends)
9.3. By Industry Verticals (Pharmaceuticals, Nutraceuticals, Cosmetics, Veterinary Health, Sports Nutrition)
9.4. By Company Size (Large Pharma, Mid-Sized Nutraceuticals, SMEs/Private Label Retailers)
9.5. By Fill Type (Omega-3 Oils, Vitamins & Minerals, Botanicals, Rx APIs, Beauty-from-Within Actives)
9.6. By Release Profile (Immediate, Enteric/Acid-Resistant, Sustained, Chewable, Mini-Softgels)
9.7. By Open and Customized Formulations (Standard SKUs vs. Tailor-Made Softgels)
9.8. By Region (England, Scotland, Wales, Northern Ireland)
10.1. Client Landscape and Cohort Analysis (Pharma, Nutraceuticals, Retail Chains, SMEs)
10.2. Product Development Needs and Decision-Making Process
10.3. Effectiveness and ROI Analysis (Category Velocity, Repeat Purchases, Shelf Turnover)
10.4. Gap Analysis Framework
11.1. Trends and Developments (Vegetarian Capsules, TiO₂-Free Shells, Mini-Softgels, Online Retail)
11.2. Growth Drivers (Nutraceutical Demand, Aging Population, Regulatory Clarity, E-commerce Penetration)
11.3. SWOT Analysis for UK Soft Gelatin Capsules Market
11.4. Issues and Challenges (Raw Material Supply, Certification Complexity, Stability, Energy Costs)
11.5. Government Regulations (MHRA Licensing, FSA Supplement Rules, EU/Pharmacopoeia Standards, Labeling & Advertising)
12.1. Market Size and Future Potential for Online Sales of Softgels in UK
12.2. Business Model and Revenue Streams (Subscriptions, Private Label, Bundles)
12.3. Delivery Models and Types of Products Offered (Pharmacy Click & Collect, D2C, Retailer Sites)
15.1. Market Share of Key Players in UK Softgel Market Basis Revenues
15.2. Benchmark of Key Competitors in UK Soft Gelatin Capsules Market (Company Overview, USP, Business Strategies, Business Model, Number of Encapsulation Lines, Revenues, Pricing per Thousand, Technology Used, Best-Selling SKUs, Clients, Tie-Ups, Marketing, Recent Developments)
15.3. Operating Model Analysis Framework
15.4. Gartner Magic Quadrant (Technology & Compliance Leadership)
15.5. Bowman’s Strategic Clock for Competitive Advantage
16.1. Revenues, Forecast
17.1. By Market Structure (In-House and Outsourced Softgel Manufacturing)
17.2. By Capsule Type (Bovine, Fish, Vegetarian, Tapioca/Starch)
17.3. By Industry Verticals (Pharma, Nutraceuticals, Cosmetics, Veterinary, Sports Nutrition)
17.4. By Company Size (Large Enterprises, Mid-Sized, SMEs)
17.5. By Fill Type (Omega-3, Vitamins, Botanicals, Rx, Beauty)
17.6. By Release Profile (Immediate, Enteric, Sustained, Chewable, Mini)
17.7. By Open and Customized Formulations
17.8. By Region (England, Scotland, Wales, Northern Ireland)
Discuss a Customized Research Scope
Custom research scope • Tailored insights • Industry expertise
Research Methodology
Step 1: Ecosystem Creation
We begin by mapping the entire ecosystem of the UK Soft Gelatin Capsules Market, identifying both demand-side and supply-side entities. On the supply side, this includes gelatin producers (bovine, fish, vegetarian/carrageenan), excipient and plasticiser suppliers, contract development and manufacturing organisations (CDMOs), pharmaceutical and nutraceutical brand owners, packaging vendors, and logistics partners. On the demand side, we identify pharmacy chains, grocery and health-food retailers, e-commerce platforms, hospitals, and end-consumers with specific health-use cases such as omega-3 supplementation or vitamin D intake. From this ecosystem, we shortlist 5–6 leading manufacturers and CDMOs based on their financial disclosures, UK market presence, client partnerships, and product portfolio strengths. Sourcing for this stage relies on government trade statistics (e.g., DEFRA fisheries, ONS livestock data), company filings, MHRA certification records, and industry publications. This allows us to collate macro-level indicators like input availability (fish landings, cattle herds), pharmacy network density, and import volumes, which underpin the UK’s softgel market structure.
Step 2: Desk Research
The second stage involves conducting exhaustive desk research through diverse secondary and proprietary databases. This includes detailed analysis of market fundamentals such as prescription dispensing volumes, nutraceutical uptake, and distribution footprint across the UK. Industry-level insights are aggregated from government publications, financial filings, press releases, and audited annual reports of leading players such as Catalent, HBI EuroCaps, Aenova, SIRIO, and Thermo Fisher. During this stage, we build a baseline of the market by examining aspects like number of production lines, installed capacity, technology adoption (enteric release, TiO₂-free systems), and retailer participation in private-label softgel programs. This creates a comprehensive foundation of the supply-demand balance and enables us to understand competitor positioning and market attractiveness.
Step 3: Primary Research
Following desk research, we conduct structured in-depth interviews with C-level executives, QA/QP managers, production heads, procurement leads, and retail buyers within the UK softgel ecosystem. These interactions validate hypotheses on capacity utilisation, lead times, technology gaps, and pricing thresholds (per-thousand-capsule campaigns). A bottom-up approach is employed by aggregating revenue contributions and output volumes of individual CDMOs and brand owners, while a top-down validation is cross-checked using pharmacy dispensing volumes and nutraceutical category performance. As part of the validation strategy, disguised interviews are conducted under the guise of potential clients. This ensures authenticity of operational and financial data, while providing visibility into revenue streams, value chains, certification processes, and ESG-linked investments.
Step 4: Sanity Check
Finally, a sanity check is performed by reconciling bottom-to-top calculations (line-level throughput and company-level disclosures) with top-to-bottom modelling (macro demand flows, pharmacy and retail footprint, livestock and fish-oil inputs). This triangulation ensures the robustness of the market sizing and growth analysis. Multiple iterations of modelling are conducted to remove anomalies and align outputs with official UK government statistics, regulatory records, and validated company data.
See What's Inside the Report
Get a preview of key findings, methodology and report coverage
Frequently Asked Questions
01 What is the potential for the UK Soft Gelatin Capsules Market?
The UK Soft Gelatin Capsules Market demonstrates strong potential, supported by macroeconomic, demographic, and healthcare trends. With the UK population reaching 69.3 million and an ageing cohort of 12.7 million people aged 65+, demand for easy-to-swallow formats such as softgels continues to rise. Nutraceutical adoption in pharmacies and online channels has been reinforced by wide retail coverage, with 12,009 active community pharmacies dispensing both prescription and supplement products. These structural factors underline the market’s long-term growth potential across pharmaceuticals, nutraceuticals, and beauty-from-within applications.
02 Who are the Key Players in the UK Soft Gelatin Capsules Market?
The UK Soft Gelatin Capsules Market is led by a mix of domestic and global players. Catalent Softgel & Oral Technologies, HBI EuroCaps (UK), and Thermo Fisher Scientific (Patheon) dominate with large-scale manufacturing assets, advanced enteric technologies, and regulatory expertise. Aenova Group, SIRIO Europe (Ayanda), and Softigel by Procaps bring strong European and global capacity. Other notable participants include Captek Softgel International, Robinson Pharma, Best Formulations, and Geltec Pvt. Ltd., supplying the UK market via imports and partnerships with brand owners and retailers.
03 What are the Growth Drivers for the UK Soft Gelatin Capsules Market?
The UK softgel segment is driven by structural macroeconomic factors. Prescription flows remain high, with 1.21 billion items dispensed in England and 1.08 billion processed through electronic systems, ensuring reliable channels for Rx/OTC softgels. Nutraceutical demand is underpinned by fisheries and livestock resources: UK vessels landed 719,000 tonnes of sea fish while cattle and calf herds stood at just under 9.2 million, securing omega-3 and gelatin inputs. Combined with e-commerce expansion and consumer preference for bioavailable formats, these drivers fuel consistent category demand.
04 What are the Challenges in the UK Soft Gelatin Capsules Market?
The market faces several challenges that influence capacity, compliance, and input economics. On the supply side, the UK imported 743,000 tonnes of fish and fish products, exposing the industry to global logistics risks, oxidation control, and customs lead times. Domestically, cattle herds declining below 9.2 million head create volatility for bovine gelatin supply. Labour remains constrained, with 728,000 job vacancies across the economy, limiting skilled GMP roles in QA/QP and manufacturing. These factors, combined with regulatory scrutiny on TiO₂ and sustainability, pose hurdles for consistent throughput and cost-effective expansion.
License Options
PDF + Excel
Complete report package
$4,000
Excel Only
Data and analytics
$2,500
Custom Sections
Starts from $100
$0